American College of Clinical Pharmacy
      Search      Cart
         
ACCP Report

Chisholm-Burns, Cohen, Kelly, Nutescu, O’Connell, and Taber to Receive ACCP Honors

Marie A. Chisholm-Burns, Lawrence Cohen, Kim L. Kelly, Edith A. Nutescu, Mary Beth O’Connell, and David J. Taber have been selected by the College’s Awards Committee to receive ACCP’s prestigious 2020 Russell R. Miller Award, Robert M. Elenbaas Service Award, C. Edwin Webb Professional Advocacy Award, Therapeutic Frontiers Lecture Award, Education Award, and Clinical Practice Award, respectively.


Chisholm-Burns

Russell R. Miller was the founding editor of the College’s journal Pharmacotherapy. The Russell R. Miller Award is presented in recognition of substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy. Marie A. Chisholm-Burns, Pharm.D., MPH, MBA, FCCP, FASHP, FAST, is dean and a tenured professor of pharmacy at the University of Tennessee Health Science Center College of Pharmacy. She also serves as executive director of the Drug Discovery Center in the College of Pharmacy, a professor in the Department of Surgery in the College of Medicine, and a member of the graduate faculty in the College of Graduate Health Sciences. At the time of her nomination, Chisholm-Burns had published more than 150 papers in peer-reviewed journals with 8 more manuscripts in progress or accepted for publication, 39 book chapters, over 120 abstracts, and several creative works in news, media reports, and instructional websites. Dr. Rita Alloway, research professor of medicine and director of transplant clinical research and transplant pharmacy residency and fellowship at the University of Cincinnati, commented on Chisholm-Burns’ important contributions in improving health outcomes in her letter of nomination:

Foremost among Dr. Chisholm-Burns’ accomplishments is her creation of the Medication Access Program (MAP), whose mission is to increase access to medications for solid-organ transplant recipients (Dr. Chisholm-Burns is Founder and Director of MAP). MAP is a statewide network that facilitates patients’ access to medications through a variety of mechanisms, such as enrollment into Medicaid, Medicare, private insurance, foundations, and pharmaceutical companies’ assistance programs. MAP’s multidisciplinary team of clinical pharmacists, physicians, nurses, social workers, and other professionals and support personnel work together to ensure that patients receive high-quality, cost-effective, culturally competent care including medication therapy management. Since October 1999, MAP has helped more than 990 solid-organ transplant recipients receive nearly $84 million in prescription medications. Dr. Chisholm-Burns’ MAP-related accomplishments have been well documented in peer-reviewed journal publications. For example, a study Dr. Chisholm-Burns published in the American Journal of Health-System Pharmacy demonstrated the racially/ethnically diverse population of transplant recipients served by MAP experienced improved blood pressure, cholesterol, and blood glucose levels, had fewer graft (transplanted organ) rejections, and had better quality of life following enrollment into the program compared to pre-enrollment…. As a result of the successes achieved by this program, MAP serves as an exemplar for similar programs across the country.

Chisholm-Burns serves as a reviewer for Pharmacotherapy and has previously received several other prestigious honors, including the Inspiring Women in STEM Award, the ASHP-ABHP Joint Leadership Award, the Chauncey I. Cooper Pharmacist Leadership Award, the AST Clinician of Distinction Award, and the APhA-APRS Research Achievement Award. She received ACCP Fellow recognition in 2001.


Cohen

Robert M. Elenbaas served as ACCP’s founding executive director from 1986 through 2003. During his 17-year tenure, he exemplified the characteristics of a servant-leader committed to the advancement of clinical pharmacy and ACCP. The Elenbaas Service Award is given only when a particularly noteworthy candidate is identified in recognition of outstanding contributions to the vitality of ACCP or to the advancement of its goals that are well above the usual devotion of time, energy, or material goods. Lawrence Cohen, Pharm.D., FCCP, FASHP, FCP, FNAP, BCPP, is a tenured professor of pharmacotherapy, coordinator of interprofessional education, and coordinator of continuing professional education in the Department of Pharmacotherapy at the University of North Texas System College of Pharmacy. A past president of ACCP, Cohen has been actively engaged in service to the College and the pharmacy profession throughout his career. Dr. William A. Kehoe, also a past ACCP president and now emeritus professor of pharmacy practice at the Thomas J. Long School of Pharmacy and Health Sciences at the University of the Pacific, wrote in his letter of support:

While I joined ACCP shortly after it was founded, I pretty much stayed in the background. Larry, on the other hand, was already very involved. I first began to work with him in the early years of the CNS PRN, which he was instrumental in establishing. We became friends, and he began to encourage me to help him move it forward…. That was an important milestone for me in terms of getting more involved with ACCP. Over the years, I’ve seen Larry do that with so many others. Whether it’s been helping members get involved with committees or other working groups, seeking out younger members to speak in our programs, or looking for those whose next step might be to run for office, Larry is a champion for them. I’ve watched him do this in the background for years, and I think it’s really served ACCP well. I know for me personally, I will always consider Larry one of the most important people in getting me more involved with the College and ultimately leading to my being able to serve as an officer…. If you happen to know Larry, you will know that he’s involved with many other healthcare organizations at a national and international level. He’s always looking for ways to promote ACCP as a potential collaborating organization. He thinks innovatively, and I think he’s enhanced our image among other organizations as he represents us. And, even though Larry is involved with so many other organizations, ACCP is his home base.

At the time of his nomination, Cohen had published more than 70 peer-reviewed manuscripts, given over 270 professional presentations, and served as a reviewer for 16 journals, including the Annals of Pharmacotherapy, American Journal of Pharmaceutical Education, Journal of Medical Economics, Journal of the American Medical Directors Association, American Pharmacy, and Journal of the American College of Clinical Pharmacy. He has also served on the editorial boards of several journals. Cohen was elected as a Fellow of ACCP in 1996, a fellow of the American College of Clinical Pharmacology in 2012, and a fellow of the American Society of Health-System Pharmacists in 1993.


Kelly

The C. Edwin Webb Professional Advocacy Award is given only when a particularly noteworthy candidate is identified who has made outstanding contributions to the visibility and value of clinical pharmacy in national policy, intraprofessional, and/or interprofessional arenas. This award recognizes an ACCP member who has assembled a record of mentoring others who have gone on to assume a health professions and/or health policy leadership role and is recognized as an ambassador for clinical pharmacy both within and outside the profession. Kim L. Kelly, Pharm.D., FCCP, BCPS, CPC, CEC, CDTC, is president of Kelly Diabetes Associates, LLC. Dr. Dawn Havrda, associate dean for Academic Affairs and Assessment at the University of Tennessee Health Science Center, wrote in her letter of support:

Early in his career, Dr. Kelly was part of creating what clinical pharmacy is today. In 1978, he chaired a Special Interest Group (SIG) of the American Society of Hospital Pharmacists in Clinical Pharmacy. A year later in 1979, he became one of the 29 founding members of the American College of Clinical Pharmacy and was the founding president of ACCP. After his term as president, he became the chairman of the Board of Directors for the Research Institute of ACCP. He has sustained evidence of continued service to ACCP through membership on many committees, chairing a PRN, and being one of the first Fellows of ACCP. Dr. Kelly also served on the National Committee on Clinical Pharmacy as a Specialty from 1980-1988; this committee was charged with developing a petition for consideration by the Board of Pharmaceutical Specialties (BPS) to recognize clinical pharmacy as a specialty area within the practice of pharmacy. The committee ultimately recommended Pharmacotherapy be recognized as a specialty by BPS. Dr. Kelly remains an involved member of ACCP and is an active member of many of the PRNs. He continues to volunteer to serve within ACCP and move the pharmacy profession forward. Dr. Kelly takes an interest in individuals. He is approachable and does not hesitate to offer his assistance to guide and mentor fellow pharmacist clinicians. Personally, I have worked with Dr. Kelly in the Endocrine & Metabolism PRN and I feel he is one of the strongest advocates for pharmacy in healthcare reform as a provider of services, for adequate reimbursement for pharmacy services, and pharmacists providing an advanced role in educating and managing diabetes and its comorbidities. His enthusiasm is contagious and sustaining, especially when you consider he has been a pioneer for clinical pharmacy since the origin of ACCP and board certification over 35 years ago.

At the time of his nomination, Kelly served on the Board of Directors of the College Diabetes Network, was a reviewer for Pharmacotherapy, and was a member of 16 professional society affiliations, including the American Association of Clinical Endocrinologists, American Association of Diabetes Educators, American Association of Nurse Practitioners, and American Diabetes Association.


Nutescu

The ACCP Therapeutic Frontiers Lecture Award recognizes an individual, including ACCP member and nonmember nominees, who has made outstanding contributions to pharmacotherapeutics in his or her field. Among the criteria for this award is the broad acknowledgment that the recipient is currently considered at the leading edge of research in the field. Edith A. Nutescu, Pharm.D., M.S., FCCP, is the Michael Reese Endowed Professor in Cardiovascular Pharmacotherapy and head of the Department of Pharmacy Practice at the University of Illinois at Chicago. She also serves as a clinical pharmacist with the Personalized Medicine Program, Cardiovascular Pharmacogenomics, and the Department of Ambulatory Care Pharmacy Services at the University of Illinois Hospital & Health Sciences System in Chicago. At the time of her nomination, Nutescu had published more than 150 papers in peer-reviewed journals with 13 more manuscripts in progress, 15 papers in non–peer-reviewed journals, 20 book chapters, and over 100 abstracts, among them several creative works in news and media reports. Dr. Robert B. Parker, a professor in the Department of Clinical Pharmacy at the University of Tennessee College of Pharmacy, wrote in his letter of support:

The impact of her scholarship cannot be overstated. One of her most important contributions is identification of genetic variants that affect the disposition and response to warfarin and clopidogrel in racial and ethnic minorities. Most of the previous work involved only Caucasian patients, but Dr. Nutescu and her collaborators were the first investigators to identify additional novel genetic variants that affected warfarin response, specifically in African-Americans. Dr. Nutescu is a leader in showing that incorporating that information into clinical practice leads to improved anticoagulation outcomes in minority (mostly African-American) populations. Her work on identifying barriers to high-quality healthcare and the subsequent development of innovative delivery models to overcome these barriers in minority populations is highly significant both for local populations in the Chicago area and across the country. Based on her publications, grants, and presentations, she is clearly an internationally recognized leader, both within and outside pharmacy, in improving outcomes of anticoagulant therapy, particularly in minority populations. Her work with anticoagulant safety and efficacy in underserved minorities fills a unique niche in that these patients are at increased risk for adverse outcomes. As a result of her important contributions, she is also a frequent invited speaker at international/national meetings.

Nutescu serves as a scientific editor for Pharmacotherapy and has previously received several other prestigious honors, including the ACCP Distinguished Researcher Award, the American Society of Health-System Pharmacists (ASHP) Research and Education Foundation Medication Use Safety Excellence Award, the International Society for Pharmacoeconomics and Outcomes Research Best Research Award, the ASHP Distinguished Service Award, and the 2019 ACCP Russell R. Miller Award. She received ACCP Fellow recognition in 2007, served on the ACCP Board of Regents from 2011 to 2013, and chaired the Pharmacotherapy Board of Directors from 2015 to 2017.


O'Connell

The ACCP Education Award recognizes an ACCP member who has made substantial and outstanding contributions to clinical pharmacy education at either the professional or postgraduate level. Mary Beth O’Connell, Pharm.D., FCCP, FASHP, FNAP, AGSF, BCPS, is a tenured professor of pharmacy practice in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University and a faculty associate in the Institute of Gerontology at Wayne State University. Dr. Insaf Mohammad, clinical assistant professor in the Department of Pharmacy Practice, wrote in her letter of support:

I joined the faculty at Wayne State University in August 2017 as a Clinical Assistant Professor in the Department of Pharmacy Practice. Dr. O’Connell has demonstrated a keen interest in my development and has shown me encouragement that is unmatched. As a junior faculty member, Dr. O’Connell has continued to show her eagerness to mentor me, meanwhile demonstrating her commitment to novel educational methods – she is a brilliant mastermind in this regard. For instance, she is a faculty leader at a residential treatment program known as Vista Maria – a home for adolescent girls who have endured social issues and various forms of abuse. She engages our student pharmacists in this program – arranging education sessions that they lead focusing on contraception, behavioral health, and other health-related topics. She merges her love for women’s health with an unmet need in this program and has invited me to be a junior faculty participant. As I watched the way she engages students and the adolescent members of the home, I realized that her passion for special populations far transcends what is written in the curriculum vitae and teaching portfolio. Her genuine care for enhancing my awareness of such community gaps – and for engaging students in vulnerable patient populations – is uniquely representative of her many talents.

At the time of her nomination, O’Connell had published over 60 papers in peer-reviewed journals as well as 19 book contributions. She has presented extensively at professional and scientific meetings (including ACCP meetings), served as a member of several ACCP committees and task forces, and served as ACCP president in 2002–2003.


Taber

The ACCP Clinical Practice Award is given to a College member who has made substantial and outstanding contributions to clinical pharmacy practice. Criteria considered in identifying potential candidates include exceptional leadership in developing innovative clinical pharmacy services and sustained excellence in providing them. David J. Taber, Pharm.D., M.S., BCPS, is an associate professor in the Division of Transplant Surgery at the Medical University of South Carolina (MUSC), an adjunct assistant professor at the MUSC College of Pharmacy, an associate member of the university’s College of Graduate Studies, and an associate graduate faculty member at the MUSC College of Health Professionals. Taber is an innovative pioneer, elevating the level of pharmacy practice in the field of transplantation. Dr. Nicole Pilch, director of Regulatory Affairs/Accreditation and clinical associate professor in the Department of Pharmacy and Clinical Sciences at the South Carolina College of Pharmacy, highlighted Taber’s recent contributions to the practice of clinical pharmacy in her letter of support:

Dr. Taber’s most recent VA project entitled “Improving Immunosuppression Monitoring and Care Coordination in Veteran Transplant Recipients” is an evolution from several projects that Dr. Taber has led throughout the years. Dr. Taber’s current intervention study demonstrates the substantial, innovative impact that pharmacists can make in the lives of transplant patients. Pre-intervention: 91% of patients had discrepancies in their documented medication regimens between VA and non-VA systems, 40% had inadequate immunosuppression drug levels measured to monitor therapy, and more than 80% had duplicative laboratory assessments. His study has demonstrated in a multi-center fashion that pharmacists can improve monitoring and outcomes for these VA transplant recipients through the use of a dashboard. His initial analysis demonstrated an improvement in immunosuppression monitoring for these patients, increasing from approximately 58% at baseline to over 90% with the most current data. In addition, Dr. Taber’s study of veterans with an accurate transplant diagnosis improved from 88% to 100%. Also, pharmacists’ interventions were able to increase veteran transplant recipients seen within a year from 88% to 96%. This innovative clinical pharmacy service is a demonstration of his contribution to sustained excellence in providing clinical pharmacy services as well as patient outcomes.

Taber received the 2017 ACCP Immunology and Transplantation PRN Distinguished Investigator Award and has twice been recognized as Pharmacy Residency Preceptor of the year (2007–2008 and 2010–2011). At the time of his nomination, he had published more than 115 peer-reviewed articles and been involved in over 120 poster presentations as author or coauthor.

Members of the 2019 ACCP Awards Committee were Mary Amato (chair), Kristi Kelley (vice chair), Ty Kiser (secretary), Jacquelyn Bainbridge, Melody Berg, Kelly Caudle, Alexandre Chan, Lisa Davis, Pramodini Kale-Pradhan, Christina Madison, LeAnn Norris, Chasity Shelton, Michael Thomas, and Kathleen Vest.